AI Summary
This article discusses the development and use of human recombinant 64Cu-rHCF as a contrast agent for positron emission tomography (PET), specifically targeting the kidney glomerulus. The use of this contrast agent could potentially provide improved imaging capabilities for the kidney, allowing for better diagnosis and monitoring of kidney conditions. The development of targeted contrast agents like 64Cu-rHCF could lead to more precise and efficient imaging techniques for various medical applications.